Consistent with gene expression profiling data of AML blasts cells [22] we observed differential expression of CES1 being more prominent in (myelo) monocytic M4 and M5 FAB classification subtypes than other subtypes (Figure 3A). This evidence concerns the gene CES1 and acute myeloid leukemia.